MedTrace Logo

Adherence Intervention for HIV-infected Drug Users

NCT02907697 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 132

Last updated 2022-07-25

No results posted yet for this study

Summary

Many people living with HIV use illicit drugs, which leads to worsened health outcomes and increased transmission of HIV due to poor adherence to medication regimens. This research will develop an intervention targeting medication adherence that is tailored to the unique needs of HIV-infected drug users. This research will promote adherence and improve treatment outcomes among HIV-infected drug users thereby minimizing the development of drug resistant strains of HIV and reducing transmission.

Conditions

  • HIV
  • Substance Use

Interventions

BEHAVIORAL

Life Steps-Drug Use

BEHAVIORAL

General Health Education

Sponsors & Collaborators

  • Brown University

    collaborator OTHER

  • University of Texas at Austin

    lead OTHER

Principal Investigators

  • Kasey Claborn, PhD · The Unviersity of Texas

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-01
Primary Completion
2022-10-01
Completion
2022-12-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02907697 on ClinicalTrials.gov